Pharma channel feed – Endpoints News

Pharma channel feed

Boehringer Ingelheim flies the white flag as last holdout surrenders in war over a $20B AbbVie gold mine

7 years ago

Biopharma BD teams are speeding into the fast lane — cash in hand — as dealmaking continues to heat up in Q1 offensive

7 years ago

Daiichi Sankyo faces FDA challenges on missing data, credibility and safety concerns in hunt for 2 new drug OKs

7 years ago

‘Too big to care’: Sweeping lawsuit accuses Teva of colluding with other generic makers to keep prices high

7 years ago

Engulfed in legal trouble, bankruptcy could be the answer for opioid drugmaker Insys

7 years ago

Puma investors fret, as Nerlynx Q1 sales fall uncomfortably short of Wall Street estimates

7 years ago

ICER chastises J&J for overpricing depression drug esketamine ‘where there is such need for treatment’

7 years ago

Takeda inks a pair of sales to Novartis and J&J for up to $5.7B, handing over 485 staffers

7 years ago

List prices in drug ads on TV coming as CMS finalizes rule

7 years ago

Work with Florida on its drug import program, Trump tells Azar — report

7 years ago

Tillman Gerngross isn't out to impress you with biobucks, but here are 3 partner deals that should

7 years ago

Pfizer buys a rare disease biotech for $340M-plus, putting them on a path to compete with BioMarin

7 years ago

Rattle and hum: Roche, PTC post update on their SMA drug as a shaken Biogen faces yet another franchise buster

7 years ago

Allergan chief Saunders takes a painful $2.5B hit on an ugly PhIII flop

7 years ago

Catching Catalyst Pharma by surprise, FDA approves Jacobus LEMS drug for pediatric patients — based on adult data

7 years ago

Watch out AbbVie and J&J, AstraZeneca just took another big swing at one of your star cancer drug franchises

7 years ago

Bill Haney's Skyhawk spears another marquee alliance for its work drugging RNA in Takeda neuro pact

7 years ago

Pfizer enters Alnylam, Ionis' TTR turf with early approval for cardiomyopathy drug, carrying a $225K price tag

7 years ago

Hit by setbacks, Lundbeck's Deborah Dunsire inks a $400M cannabinoid buyout, adding a discovery site

7 years ago

The (corrected) list of the world's top 20 pharma companies

7 years ago

FDA rejects Acacia's lead drug — again — due to the same manufacturing issue

7 years ago

As backlash mounts in the wake of a disastrous PhIII flop, Eisai goes deeper with 2 new hires

7 years ago

Did a disaster crush your stock in 2018? These biotechs were happy to come up with some rich compensation deals for the CEO anyway

7 years ago

Insys founder, former execs face decades in jail after being found guilty in landmark opioid case

7 years ago

First page Previous page 273 274 275276277 278 279 Next page Last page